| 25 May 2026 |
NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend |
7.5 |
20mg |
22.3mg |
+11.4% |
96.67% |
Lab A |
| 24 May 2026 |
LGD-4033 (Ligandrol) Raw |
7.4 |
1g |
1.2g |
+15.3% |
95.94% |
Lab E |
| 24 May 2026 |
4-AP (4-anilino-piperidine / N-phenyl-4-piperidinamine) CAS 23056-29-3 |
10.0 |
100g |
100.7g |
+0.7% |
95.58% |
Lab F |
| 24 May 2026 |
N-Acetyl Epitalon Amidate |
9.5 |
15mg |
16.5mg |
+10.2% |
97.31% |
Lab G |
| 24 May 2026 |
Retatrutide |
9.2 |
24mg |
22.4mg |
-6.7% |
99.80% |
No Label / Silver Crimp / Green Cap |
| 24 May 2026 |
Selank 10mg + Semax 10mg Blend |
9.1 |
50mg |
50.7mg |
+1.3% |
98.68% |
Lab D |
| 24 May 2026 |
SS-31 |
8.3 |
5mg |
4.6mg |
-7.6% |
95.52% |
Lab G |
| 23 May 2026 |
BPC157 10mg + TB500 10mg Blend |
8.9 |
15mg |
13.1mg |
-12.8% |
99.24% |
Lab G |
| 23 May 2026 |
KPV |
8.0 |
2mg |
1.9mg |
-2.8% |
95.80% |
Lab A |
| 23 May 2026 |
Stanozolol (Winstrol) Raw |
10.0 |
5g |
4.7g |
-5.7% |
99.43% |
Lab G |
| 23 May 2026 |
Vesugen |
9.2 |
2mg |
2.3mg |
+17.0% |
96.41% |
Lab E |
| 23 May 2026 |
YK-11 Raw |
9.0 |
10g |
8.6g |
-13.5% |
95.60% |
Lab E |
| 23 May 2026 |
BPC157 5mg + TB500 5mg Blend |
7.6 |
15mg |
13.0mg |
-13.0% |
99.67% |
Lab B |
| 21 May 2026 |
Ostarine (MK-2866) |
8.2 |
25mg |
27.5mg |
+10.1% |
97.36% |
Lab A |
| 21 May 2026 |
Testagen |
10.0 |
30mg |
28.2mg |
-6.0% |
96.00% |
Lab C |
| 21 May 2026 |
Estradiol Cypionate |
8.2 |
300mg/ml |
367.8mg/ml |
+22.6% |
96.67% |
Lab D |
| 20 May 2026 |
Retatrutide |
10.0 |
10mg |
10.3mg |
+3.0% |
99.90% |
No Label / Silver Crimp / Yellow Cap |
| 17 May 2026 |
CJC-1295 w/o DAC 10mg + IPA 10mg Blend |
9.1 |
50mg |
51.2mg |
+2.4% |
96.96% |
Lab E |
| 26 Jan 2026 |
Cardiogen |
7.7 |
2mg |
2.0mg |
-0.2% |
96.32% |
Lab A |
| 22 Jan 2026 |
Retatrutide |
6.5 |
10mg |
10.9mg |
+9.0% |
99.80% |
No Label / Silver Crimp / Yellow Cap |
| 19 Jan 2026 |
Equipoise (Boldenone Undecylenate) |
8.0 |
300mg/ml |
372.8mg/ml |
+24.3% |
99.18% |
Lab F |
| 19 Jan 2026 |
Liraglutide |
5.3 |
50mg |
45.1mg |
-9.8% |
98.03% |
Lab F |
| 6 Jan 2026 |
Dapoxetine |
8.6 |
50mg |
60.9mg |
+21.8% |
95.07% |
Lab B |
| 6 Jan 2026 |
GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg |
8.7 |
15mg |
13.2mg |
-12.1% |
97.43% |
Lab G |
| 29 Dec 2025 |
KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg |
6.6 |
5mg |
5.2mg |
+4.8% |
99.11% |
Lab D |
| 29 Dec 2025 |
Super Shred |
8.0 |
300mg/ml |
275.5mg/ml |
-8.2% |
99.91% |
Lab C |
| 29 Dec 2025 |
T4 (Levothyroxine) |
6.8 |
50mg |
43.6mg |
-12.7% |
95.96% |
Lab F |
| 18 Dec 2025 |
Retatrutide |
7.7 |
36mg |
40.5mg |
+12.5% |
99.80% |
White Label / Silver Crimp / Blue Cap |
| 13 Dec 2025 |
Retatrutide |
7.8 |
10mg |
9mg |
-10.0% |
99.60% |
No Label / Silver Crimp / Yellow Cap |
| 5 Dec 2025 |
Andarine S4 |
8.8 |
100mg |
121.2mg |
+21.2% |
96.89% |
Lab G |
| 5 Dec 2025 |
Trenbolone Enanthate |
6.3 |
300mg/ml |
259.4mg/ml |
-13.5% |
98.72% |
Lab D |
| 24 Nov 2025 |
Retatrutide |
9.1 |
20mg |
19.87mg |
-0.7% |
99.53% |
No Label / Gold Crimp / Clear Cap |
| 23 Nov 2025 |
Teriparatide |
8.3 |
5mg |
5.7mg |
+13.8% |
97.27% |
Lab B |
| 17 Nov 2025 |
CJC-1295 w/o DAC 5mg + IPA 5mg Blend |
7.8 |
15mg |
14.7mg |
-2.2% |
98.41% |
Lab A |
| 17 Nov 2025 |
Tirzepatide Raw |
6.6 |
100g |
89.1g |
-10.9% |
99.97% |
Lab A |
| 14 Nov 2025 |
Retatrutide |
6.5 |
5mg |
4.7mg |
-6.0% |
99.40% |
No Label / Silver Crimp / Blue Cap |
| 14 Nov 2025 |
1-Boc-4-(2-fluorophenylamino)piperidine CAS 887583-57-5 |
7.1 |
10g |
11.5g |
+14.5% |
95.01% |
Lab F |
| 14 Nov 2025 |
Hyaluronic acid |
7.3 |
50mg |
57.7mg |
+15.3% |
95.84% |
Lab F |
| 14 Nov 2025 |
IGF-1 LR3 |
9.5 |
10mg |
11.2mg |
+11.9% |
96.30% |
Lab E |
| 14 Nov 2025 |
MT-1 |
8.6 |
10mg |
12.3mg |
+23.5% |
98.53% |
Lab F |
| 14 Nov 2025 |
Turinabol |
10.0 |
25mg |
25.1mg |
+0.4% |
96.48% |
Lab F |
| 5 Nov 2025 |
LGD-4033 (Ligandrol) |
6.9 |
20mg |
23.5mg |
+17.7% |
98.92% |
Lab E |
| 5 Nov 2025 |
Lipo-C 120mg |
6.6 |
100mg/ml |
85.5mg/ml |
-14.5% |
95.40% |
Lab G |
| 4 Nov 2025 |
Dianabol |
9.9 |
100mg |
94.8mg |
-5.2% |
97.86% |
Lab G |
| 17 Oct 2025 |
Tamoxifen (Nolvadex) |
10.0 |
10mg |
11.0mg |
+9.8% |
97.26% |
Lab D |